Inga Zerr, MD

Inga Zerr, MD, is the head of the Clinical Dementia Center in Göttingen (Universitätsmedizin Göttingen, Germany) and her laboratory is a cooperation partner of the German Center for neurodegenerative diseases (DZNE). The goal of DZNE is focused in identifying new markers and developing novel therapies. To accomplish this, the DZNE brings together excellent scientific expertise all over Germany and follows an interdisciplinary research approach. Prof. Zerr is one of the most reputed European scientists in the neurology field, with especial focus on rapid progressive dementias. Her scientific relevance is also attested by her long-track record of publications (h-index=60), including those reporting the discovery of novel biomarkers and those positioning worldwide consensus diagnostic criteria. 

The team of Prof. Zerr involved in the present project includes Dr. Sezgi Canaslan, a neuroscientist with more than 5 years of experience in  biomarker development with a focus on patients with proteinopatheis. She established the synuclein aggregation assay in TF at the laboratory of Prof Zerr.